Chongqing Enleijia Technology Co., Ltd. – Trademark Portfolio

Entity Type: 99

Chongqing Enleijia Technology Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include NEUBELLA. The owner is based in Chongqing.

X6-95, Building 2, Phase 3, R&D Building

Chongqing 400000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

NEUBELLA
NEUBELLA
Registered 2021

Trademark Classifications

Chongqing Enleijia Technology Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Chongqing Enleijia Technology Co., Ltd. have?

Chongqing Enleijia Technology Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Chongqing Enleijia Technology Co., Ltd. file in?

Chongqing Enleijia Technology Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Chongqing Enleijia Technology Co., Ltd.'s most well-known trademarks?

Chongqing Enleijia Technology Co., Ltd.'s registered trademark portfolio includes well-known marks such as NEUBELLA. These are among 1 currently registered trademark in the portfolio.

What is Chongqing Enleijia Technology Co., Ltd.'s trademark registration success rate?

Chongqing Enleijia Technology Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.